Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,293 recalls, newest first

Class I · High risk

Iohexol (300 mg Iodine/mL)

Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL

Terminated Labeling / mix-up BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy D-0086-2023
Class III · Low risk

Phenytoin Sodium Injection

Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.

Terminated Labeling / mix-up Acella Pharmaceuticals, LLC NDC 42192-614-05 D-0070-2023
Class III · Low risk

Phenytoin Sodium Injection

Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.

Terminated Labeling / mix-up Acella Pharmaceuticals, LLC NDC 42192-614-02 D-0069-2023
Class I · High risk

Atenolol Tablets

Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets

Terminated Labeling / mix-up Golden State Medical Supply Inc. NDC 60429-027-10 D-0019-2023
Class III · Low risk

Clonidine Hydrochloride Tablets

Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets,

Terminated Labeling / mix-up Unichem Pharmaceuticals USA INC NDC 29300-137-01 D-1541-2022
Class II · Moderate risk

Dextroamphetamine Saccharate

Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.

Terminated Labeling / mix-up Teva Pharmaceuticals USA Inc NDC 0555-0777-02 D-1539-2022
Class III · Low risk

Nighttime Sleep-Aid

Labeling: Not Elsewhere Classified: Carton incorrectly identifies product as doxylamine succinate HCl, however the product is doxylamine succinate.

Terminated Labeling / mix-up LNK International, Inc. D-1472-2022
Class I · High risk

Insulin Glargine

Labeling: Missing label: Label missing from some prefilled pens.

Terminated Labeling / mix-up Mylan Pharmaceuticals Inc NDC 49502-394-71 D-1292-2022
Class II · Moderate risk

Alcohol Swabsticks

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 67777-300-01 D-1327-2022
Class II · Moderate risk

Sterile Alcohol Prep Pads

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 67777-121-16 D-1326-2022
Class II · Moderate risk

Racepinephrine Inhalation Solution

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0487-5901-99 D-1325-2022
Class II · Moderate risk

Dakin's Solution

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0436-0672-16 D-1323-2022
Class II · Moderate risk

A&D Original Ointment

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 11523-0096-3 D-1322-2022
Class II · Moderate risk

Pataday

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-8150-01 D-1321-2022
Class II · Moderate risk

GenTeal Tears

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0518-01 D-1320-2022
Class II · Moderate risk

Miralax (Polyethylene Glycol 3350)

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 11523-7234-4 D-1319-2022
Class II · Moderate risk

Debrox

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 63029-321-01 D-1318-2022
Class II · Moderate risk

Systane Zaditor

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-4011-05 D-1317-2022
Class II · Moderate risk

Systane Balance

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-1433-02 D-1316-2022
Class II · Moderate risk

Eye-stream

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0530-04 D-1315-2022

Recalls by year